Functional defecation disorders in children: comparing the Rome II with the Rome III criteria

Rosa Burgers1, Alon D Levin, Carlo Di Lorenzo

  • 1Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands. r.e.burgers@amc.nl

Insights

The Rome III criteria identify more pediatric functional defecation disorders (FDD) than Rome II criteria. Rome III criteria are an advancement for diagnosing FDD in children, with functional constipation (FC) being more prevalent.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Research
  • Diagnostic Criteria Evaluation

Background:

  • Functional defecation disorders (FDD) are common in children.
  • Accurate diagnosis relies on standardized criteria, such as the Rome criteria.
  • Previous versions of Rome criteria may have limitations in capturing the full spectrum of pediatric FDD.

Purpose of the Study:

  • To determine the prevalence of pediatric FDD using Rome III criteria.
  • To compare FDD prevalence between Rome III and Rome II criteria.
  • To assess the impact of Rome III criteria on the diagnosis of functional constipation (FC) and functional fecal incontinence (FFI) in children.

Main Methods:

  • Chart review of patients referred to a tertiary outpatient clinic for constipation and/or fecal incontinence.
  • Standardized bowel questionnaires and physical examinations, including rectal examination, were administered.
  • Prevalence of pediatric FDD was calculated using both Rome II and Rome III criteria.

Main Results:

  • Out of 336 patients with FDD, 87% met Rome III criteria for functional constipation (FC), compared to only 34% meeting Rome II criteria for FC or functional fecal retention (P < .001).
  • Fecal incontinence was present in 75% of patients, and 49% had a palpable rectal fecal mass.
  • Functional nonretentive fecal incontinence was diagnosed in 11% of patients by both criteria sets.

Conclusions:

  • The Rome III criteria for pediatric FC are less restrictive than Rome II criteria.
  • Rome III criteria represent a significant improvement in defining and recognizing FDD in children.
  • The findings support the broader application of Rome III criteria for accurate FDD diagnosis.
Abstract

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.